In our previous study, we revealed that the mTOR inhibitor MLN0128 could suppress intrahepatic cholangiocarcinoma (ICC) development in AKT/YAP mice mainly through the induction of strong apoptosis [29]. The gene discussed is MTOR; the disease is intrahepatic cholangiocarcinoma.